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Abstract
CK4-M2GlyR, an aqueous soluble peptide derived from the transmembrane M2 segment of the glycine-gated Cl3 channel
found in postsynaptic membranes of the central nervous system, has previously been shown to increase transepithelial Cl3
and fluid secretion of epithelial monolayers. The goal of this study was to determine whether CK4-M2GlyR exerts these
effects via formation of a novel chloride conductance pathway, modulation of endogenous chloride channel activity, or a
combination of these effects. Ionic currents were recorded from isolated epithelial cells before and after treatment with the
peptide using the whole-cell configuration of the patch-clamp technique. CK4-M2GlyR increased whole-cell Cl3 currents in
all epithelial cell lines that were studied, including: Madin^Darby canine kidney cells, a human colonic epithelial cell line
(T84), and airway epithelial cells derived from a human cystic fibrosis patient (IB3-1). No evidence was found for modulation
of endogenous Cl3 channels by CK4-M2GlyR based on both the electrophysiological properties of the observed currents and
the pharmacological profile of the CK4-M2GlyR-induced current. These results suggest that CK4-M2GlyR increases Cl3
permeability in epithelial cells directly, by forming a distinct conduction pathway in cell membranes. ß 2000 Elsevier
Science B.V. All rights reserved.
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1. Introduction
The cystic ¢brosis transmembrane conductance
regulator (CFTR) protein is located in the apical
membranes of Cl3 secreting epithelia, and functions
as a cAMP activated Cl3 channel [1^3]. Mutations in
the CFTR gene result in abnormal chloride transport
across epithelial cells [4]. There are several lines of
evidence that suggest a relationship between insu⁄-
cient Cl3 transport and the pathology of cystic ¢bro-
sis (CF). For example, residual Cl3 secretion in CF
patients, presumably not mediated by CFTR, corre-
lates with preserved pancreatic function and delayed
presentation of the disease [5]. The CFTR knockout
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Abbreviations: CaM kinase, Ca2- and calmodulin-dependent
protein kinase; CF, cystic ¢brosis; CFTR, cystic ¢brosis trans-
membrane conductance regulator; DIDS, 4,4P-diisothiocyanostil-
bene-2,2P-disulfonic acid; HEPES, N-2-hydroxyethylpiperazine-
NP-2-ethanesulfonic acid; ISC, short-circuit current; KN-62, 1-
(N,O-bis[5-Isoquinolinesulfonyl]-N-methyl-L-tyrosyl)-4-ohenylpi-
perazine; M2GlyR, M2 transmembrane segment of the K-subunit
of the brain glycine receptor; MDCK, Madin^Darby canine kid-
ney; POPC, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine;
POPE, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine;
POPS, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoserine; TFE,
tri£uoroethanol; VSOAC, volume-sensitive organic osmolute
and anion channel
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mouse does not develop lung disease due to the pres-
ence of a non-CFTR Cl3 channel expressed in mur-
ine lung [6], although congenic CFTR knockout mice
which lack this non-CFTR Cl3 channel, develop se-
vere lung disease [8]. In addition, the severity of dis-
ease in the CFTR knockout mouse varies in di¡erent
organs and exhibits an inverse correlation with the
presence of this non-CFTR Cl3 conductance [7].
Collectively, these ¢ndings suggest that alternate
pathways for Cl3 transport in epithelial cells can
compensate for the loss of CFTR-mediated Cl3
transport. Synthetic channel-forming peptides shown
to increase chloride conductance in epithelial cells
could thus be useful for therapeutic intervention in
CF [9,10], particularly if the novel conductance path-
ways formed respond to the altered driving force
associated with de¢cient chloride transport.
CK4-M2GlyR (PARVGLGITTVLTMTTQSSGS-
RAKKKK) is an aqueous soluble peptide derived
from the transmembrane M2 segment of the gly-
cine-gated Cl3 channel found in postsynaptic mem-
branes of the central nervous system, and a potential
therapeutic agent for cystic ¢brosis [11]. Addition of
this lysine-modi¢ed peptide to the apical surface of
monolayers of Madin^Darby canine kidney
(MDCK) cells signi¢cantly increased short-circuit
current (ISC), hyperpolarized transepithelial potential
di¡erence, and induced £uid secretion; removal of
extracellular Cl3 inhibited these e¡ects of the peptide
[11]. In contrast, the non-modi¢ed, native M2GlyR
sequence, which was shown previously to incorporate
into lipid bilayers and self-assemble into anion-selec-
tive channels [12,13], had little e¡ect on ISC when
applied to MDCK monolayers. While this previous
work shows convincingly that CK4-M2GlyR in-
creases apical chloride permeation across MDCK
and T84 monolayers, it does not address the under-
lying mechanism by which the lysine-modi¢ed pep-
tide exerts its e¡ects on transepithelial ion transport.
In light of observations that polycationic peptides
such as protamine and poly-lysine can activate en-
dogenous chloride channel activity in some cell types
[14,15] and that the unmodi¢ed M2GlyR sequence
has minimal e¡ects on ISC in epithelial monolayers,
it is possible that CK4-M2GlyR may act, at least in
part, by an indirect mechanism rather than channel
formation.
The goal of this study was to determine whether
CK4-M2GlyR increases apical chloride permeation
via formation of a novel chloride conductance path-
way, modulation of endogenous chloride channel ac-
tivity, or a combination of these e¡ects. The ability
of CK4-M2GlyR to increase chloride current in iso-
lated epithelial cells was assessed and compared to
that of a scrambled permutation of the peptide. In
addition, we looked for modulation by CK4-
M2GlyR of other Cl3 channels expressed in secre-
tory epithelia. Experiments were designed speci¢cally
to test for e¡ects of CK4-M2GlyR on: CFTR, the
cAMP-activated Cl3 channel; ClC-2, the inwardly
rectifying, voltage-gated Cl3 channel; the volume-
sensitive organic osmolute and anion channel
(VSOAC); and the Ca2-dependent Cl3 channel
regulated by the Ca2- and calmodulin-dependent
protein kinase (CaM kinase) [16,17]. Preliminary re-
ports of these studies have been published in abstract
form [18,19].
2. Materials and methods
2.1. Peptide synthesis and puri¢cation
Peptides were synthesized and puri¢ed as described
previously [10]. Aqueous stock solutions of the syn-
thetic peptides (5 mM) were dialyzed against 10 mM
N-2-hydroxyethylpiperazine-NP-2-ethanesulfonic acid
(HEPES), pH 7.4, in a dialysis cassette with a 2000
molecular weight cut o¡. Protein concentrations of
the resulting stock solutions were determined by the
micro BCA assay (Pierce, Rockford, IL, USA).
Stock solutions were stored in small volumes at
320‡C, thawed and added to solutions for immedi-
ate use (same day).
2.2. Cell culture
MDCK cells and T84 cells were obtained from the
American type culture collection (ATCC), and main-
tained in culture as described previously in detail
[20]. Brie£y, MDCK and T84 cells were grown in a
1:1 mixture of Dulbecco’s modi¢ed Eagle’s media
and Ham’s F-12 (DMEM/F12) supplemented with
5% fetal bovine serum (FBS), 100 IU/ml penicillin
G and 0.1 mg/ml streptomycin (P/S).
IB3-1 cells [21] and IB3-1 cells stably transfected
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with antisense hClC-2 cDNA [22] were obtained
from Dr. Garry R. Cutting (Johns Hopkins Univer-
sity School of Medicine, Baltimore, MD), and main-
tained in culture as previously described [21]. Brie£y,
IB3-1 cells were cultured in LHC-8 serum-free me-
dium supplemented with endothelial growth supple-
ment (15 Wg/ml), imipenem (200 Wg/ml), and tobra-
mycin (80 Wg/ml). IB3-1 cells stably transfected with
antisense hCLC-2 cDNA were maintained in the
presence of G418 (180 Wg/ml). Tissue culture £asks
were treated with Vitrogen (1:15 diluted in H2O).
All cell types were maintained as subcon£uent
monolayers in a humidi¢ed atmosphere containing
5% CO2 at 37 ‡C. For patch clamp analysis, cells
were detached from culture dishes 48 h after plating
(60^80% con£uency) using a trypsin (0.5 mg/ml) con-
taining physiological salt solution (137 mM NaCl;
2.7 mM KCl; 2.8 mM D-glucose; 3.4 mM NaHCO3 ;
0.27 mM EDTA, sodium salt), pelleted by centrifu-
gation, and resuspended in the external bath solution
(see below).
2.3. Whole-cell patch clamp recording
The whole-cell patch clamp technique [23] was
used to determine the e¡ects of the CK4-M2GlyR
peptide on whole-cell currents in isolated MDCK,
T84 cells, IB3-1 cells, and IB3-1 cells stably trans-
fected with antisense hCLC-2 cDNA [22]. The
MDCK and T84 cells were of the lineage used in
the epithelial monolayer studies [11]. Internal and
external solutions were selected to measure changes
in whole-cell chloride permeability and to minimize
cell swelling [24]. Internal recording solution (cyto-
solic) for the patch-clamp analysis contained 145 mM
Tris^HCl, 5 mM MgATP, 5 mM HEPES, pH 7.45.
The external bath solution consisted of 145 mM
Tris^HCl, 1 mM MgCl2, 1 mM CaCl2, 60 mM su-
crose, 5 mM glucose, 5 mM HEPES, pH 7.45. Chlo-
ride is the only permeant ion in this external bath
solution. To determine whether the CK4-M2GlyR-
induced current was sensitive to changes in external
chloride in the presence of physiological external so-
dium, Tris^HCl was replaced with sodium chloride
and/or sodium gluconate in the external bath solu-
tion. Current^voltage relationships obtained using
the standard recording solutions were not corrected
for liquid junction potentials (6 1 mV). Current^
voltage relationships obtained using the low chloride
extracellular solutions were corrected for liquid junc-
tion potentials (318.9 mV) that were calculated with
pClamp 7.0 (Axon Instruments, San Jose, CA,
USA), and veri¢ed under our recording conditions.
Theoretical predicted reversal potentials were calcu-
lated using the Nernst equation.
2.4. Planar lipid bilayer experiments
Planar lipid bilayer experiments were conducted as
described previously in detail [25]. Lipid bilayers
were formed across a 100 Wm aperture in the wall
of a Delrin cup. The bilayer was formed with a so-
lution containing 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine (POPC) (22.5 weight %), 1-palmito-
yl-2-oleoyl-sn-glycero-3-phosphoserine (POPS) (10
weight %) and 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphoethanolamine (POPE) (67.5 weight %) in
decane at a total lipid concentration of 50 mg/ml.
Currents were measured in KCl, with concentrations
as indicated in 10 mM HEPES, pH 7.4. The
grounded side (equivalent to extracellular) of the bi-
layer chamber is designated trans while the side to
which voltage is applied (intracellular) is the desig-
nated as the cis chamber. Peptide solutions were in-
troduced into the grounded side (trans) of the bilayer
chamber. Bilayer recordings were made with a Gene-
Clamp 500 and CV-5B-100GU headstage from Axon
Instruments (San Jose, CA). Data were acquired at
1 kHz and low-pass ¢ltered at 200 Hz. Microcal
Origin (Northhampton, MA) and either pCLAMP
6.0 or pCLAMP 7.0 (Axon Instruments, San Jose,
CA) were used for data analysis.
2.5. Circular dichroism (CD) analysis
CD spectra of the peptides in 40% tri£uoroethanol
(TFE) were measured as described previously using a
Jasco J-720 spectropolarimeter [10].
2.6. Data analyses
Statistical analyses were performed using Micro-
Cal Origin Version 5.0 (Northhampton, MA) and
Statistix for Windows Version 2.0. (Tallahasee,
FL). ANOVA was used to test for e¡ects of peptide
treatment. Multiple comparisons were performed us-
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ing Sche¡e’s procedure. Data were considered signif-
icantly di¡erent at p6 0.05.
2.7. Materials
Synthetic lipids were obtained from Avanti Polar
Lipids (Alabaster, AL). All other reagents for the
planar bilayer studies were purchased from Sigma
(St. Louis, MO) and were of the highest purity avail-
able. DMEM/F12, P/S, FBS, and G418 were pur-
chased from GIBCO Life Technologies (Rockville,
MD). LHC-8 and FBS for IB3-1 cell lines were ob-
tained from Bio£uids (Rockville, MD). Endothelial
growth supplement was obtained from Collaborative
Biomedical Products (Bedford, MA). Vitrogen was
obtained from Collagen Corporation (Palo Alto,
CA). imipenem (Primaxin0) and tobramycin
(Nebcin0) are human pharmaceuticals produced by
Merck and Co. (West Point, PA) and Eli Lilly (In-
dianapolis, IN), respectively. Ionomycin, 1-(N,O-
bis[5-Isoquinolinesulfonyl]-N-methyl-L-tyrosyl)-4-oh-
enylpiperazine (KN-62), tamoxifen, and 4,4P-diiso-
thiocyanostilbene-2,2P-disulfonic acid (DIDS) were
obtained from Sigma Chemical (St. Louis, MO).
3. Results
3.1. Does CK4-M2GlyR induce a novel Cl3 current in
isolated epithelial cells?
Initial work showing that apical treatment of
monolayers of MDCK cells with CK4-M2GlyR in-
creased ISC [10,11] suggested that this peptide should
increase whole-cell currents. To con¢rm this, patch-
clamp analysis of isolated MDCK cells was used to
measure the e¡ects of CK4-M2GlyR on whole-cell
chloride conductance. Currents were recorded during
20 mV voltage steps from 380 mV to +40 mV from
a holding potential of 340 mV, before and after
introducing peptide into the extracellular bath solu-
tion. Treatment of MDCK cells with CK4-M2GlyR
results in a gradual increase in whole-cell current
leveling o¡ after 20 min (Fig. 1). This is similar to
the time-course observed for the e¡ects of CK4-
M2GlyR on ISC in MDCK monolayers [11]. Little
if any change in whole-cell current was seen over a
similar time period for MDCK cells that were not
treated with peptide (Fig. 2A). Thus, the increase in
whole-cell current observed in cells treated with CK4-
M2GlyR is unlikely to be merely the result of an
increase in leak current over time.
To determine whether CK4-M2GlyR was capable
of increasing whole-cell currents against a di¡erent
background of endogenous channels, the e¡ect of
CK4-M2GlyR on T84 cells was measured under con-
ditions identical to those used in the MDCK studies.
Treatment of isolated T84 cells with 100 WM CK4-
M2GlyR (Fig. 2C) increased whole-cell currents with
amplitudes similar to those observed in MDCK cells
(Fig. 2B). In addition, the kinetic and voltage-depen-
dent properties of the CK4-M2GlyR-induced current
were similar in both cell types. The CK4-M2GlyR-
induced currents (Fig. 2, di¡erence) were obtained by
subtracting the initial whole-cell recordings (Fig. 2,
basal) from the currents recorded 20 min after the
indicated treatments (Fig. 2, post-treatment). As
shown in Fig. 2, the CK4-M2GlyR-induced whole
cell currents in both T84 and MDCK cells activated
in a time-independent fashion, exhibited weak, if
any, voltage-dependence, and showed no time-depen-
dent inactivation at any test potential. The current^
voltage relationship for the CK4-M2GlyR-induced
current in isolated T84 and MDCK cells is linear
and reverses at 0 mV, as expected for currents re-
Fig. 1. Treatment of MDCK cells with CK4-M2GlyR results in
a gradual increase in whole-cell chloride current. Whole-cell
currents were recorded during step changes in voltage from
380 to +40 mV (step 20) from a holding potential of 340 mV
prior to and at the designated intervals after addition of 100
WM CK4-M2GlyR to the external bath. The internal solution
contained 145 mM Tris^HCl, 5 mM MgATP, 5 mM HEPES,
pH 7.45 and the external solution contained 145 mM Tris^HCl,
1 mM MgCl2, 1 mM CaCl2, 60 mM sucrose, 5 mM glucose,
5 mM HEPES, pH 7.45.
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corded using virtually symmetrical chloride concen-
trations (Fig. 3); the reversal potential predicted by
the Nernst equation was 30.69 mV.
To determine whether the CK4-M2GlyR-induced
current was sensitive to changes in external chloride
in the presence of physiological external sodium,
chloride was substituted in part by gluconate in the
external bath solution. For an anion selective chan-
nel, the inward current should increase when the
driving force for chloride e¥ux is increased by low-
ering the external chloride concentration. A represen-
tative experiment, in which the current^voltage rela-
tionship for CK4-M2GlyR-induced currents in
MDCK cells was measured in the presence of vary-
ing concentrations of external chloride, is shown
in Fig. 4. After achieving whole cell con¢guration,
200 WM CK4-M2GlyR was added to the bath. The
current was monitored, and after 30 min the external
bath solution containing 149 mM Cl3 was changed
to a solution containing either 22.5 or 80.5 mM ex-
ternal chloride while the sodium concentration re-
mained constant at 145 mM. The inward current
(chloride e¥ux) recorded at 360 mV was larger at
80.5 and 22.5 mM external chloride compared to
virtually symmetrical (145 mM internal vs 149 mM
external) chloride (Fig. 4A). Current amplitude was
signi¢cantly greater in the 22.5 mM external chloride
solution than at 149 mM (P6 0.05) (Fig. 4A).
Changing the external chloride from 149 mM to
22.5 mM was also associated with a +16 mV shift
in reversal potential (Fig. 4B), less than the predicted
change in reversal potential obtained from the
Nernst relationship for an ideal chloride channel
Fig. 2. CK4-M2GlyR increases whole-cell chloride conductance
in isolated epithelial cells. Whole-cell currents of epithelial cells
with or without peptide treatment were recorded during step
changes in voltage from 380 to +40 mV (step 20) from a hold-
ing potential of 340 mV. Basal whole-cell currents, recorded
prior to treatment, are shown in the left column. Representative
whole-cell recordings made 20 min after changing the extracel-
lular solution are shown in the center column for: an MDCK
cell treated with no peptide (A), an MDCK cell treated with
100 WM CK4-M2GlyR (B), a T84 cell treated with 100 WM
CK4-M2GlyR (C) an MDCK cell treated with 100 WM
scrambled CK4-M2GlyR (D). Di¡erence currents, obtained by
subtracting the basal currents from the 20 min post-treatment
currents, are shown in the right column. Arrows indicate the
zero current level. The internal solution contained 145 mM
Tris^HCl, 5 mM MgATP, 5 mM HEPES, pH 7.45 and the ex-
ternal solution contained 145 mM Tris^HCl, 1 mM MgCl2,
1 mM CaCl2, 60 mM sucrose, 5 mM glucose, 5 mM HEPES,
pH 7.45.
Fig. 3. CK4-M2GlyR induces a novel current in isolated epithe-
lial cells. I-V plots of mean di¡erence currents for MDCK cells
treated with: 50 WM CK4-M2GlyR (down triangle, solid line)
(n = 11), 100 WM scrambled CK4-M2GlyR (circle, dotted line)
(n = 4) without peptide treatment (up triangle, dotted lines)
(n = 5), treated with 100 WM CK4-M2GlyR (¢lled squares, solid
line) (n = 2) and T84 cells treated with 100 WM CK4-M2GlyR
(open squares, solid line) (n = 4) are plotted at voltages from
380 to +40 mV. Error bars indicate the standard error of the
mean. CK4-M2GlyR induced currents di¡ered signi¢cantly
from the current changes observed in untreated and scrambled
CK4-M2GlyR-treated MDCK cells (at all voltages except 0 mV)
using ANOVA. The internal solution contained 145 mM Tris^
HCl, 5 mM MgATP, 5 mM HEPES, pH 7.45 and the external
solution contained 145 mM Tris^HCl, 1 mM MgCl2, 1 mM
CaCl2, 60 mM sucrose, 5 mM glucose, 5 mM HEPES, pH
7.45.
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(+46 mV). The response of the CK4-M2GlyR-in-
duced current to changes in external chloride concen-
tration is consistent with the moderate chloride se-
lectivity typical of endogenous channels. For
example, a 19-fold decrease in external chloride
from 114 mM to 6 mM caused a +33.5 mV shift in
reversal potential for the calcium activated chloride
channel from bovine trachea under recording condi-
tions where the shift in reversal potential predicted
by the Nernst equation was approximately +75 mV
[26].
3.2. Do non-speci¢c electrostatic interactions mediate
the e¡ects of CK4-M2GlyR on whole-cell chloride
conductance?
After demonstrating that CK4-M2GlyR was capa-
ble of increasing whole-cell chloride conductance in
isolated epithelial cells, it was important to explore
whether these e¡ects were via formation of novel
chloride permeation pathway, modulation of endog-
enous chloride channel activity, or a combination of
these e¡ects. If CK4-M2GlyR modulates endogenous
chloride channels as a result of nonspeci¢c electro-
static e¡ects such as those observed with protamine
and poly-lysine in canine airway cells [14,15], a
scrambled permutation of CK4-M2GlyR should be
capable of inducing increases in whole-cell chloride
current similar to those observed in cells treated with
the unscrambled peptide. To determine whether the
polycationic nature of the lysine-modi¢ed sequence
plays a role in modulating endogenous channel
activity, a scrambled peptide (ILASTRSQTGR-
Fig. 4. CK4-M2GlyR-induced current in MDCK cells is sensi-
tive to changes in external chloride. Whole-cell currents were
recorded from an isolated MDCK after treatment with 200 WM
CK4-M2GlyR at voltages from 380 mV to +40 mV. The inter-
nal solution contained 145 mM Tris^HCl, 5 mM MgATP,
5 mM HEPES, pH 7.45. The chloride concentration in the ex-
ternal solution (145 mM NaCl, 1 mM MgCl2, 1 mM CaCl2,
60 mM sucrose, 5 mM glucose, 5 mM HEPES, pH 7.45) was
varied by substituting sodium gluconate for sodium chloride to
obtain solutions with 149, 80.5 and 22.5 mM chloride. (A) The
mean current amplitude measured at 360 mV for MDCK cells
30 min after treatment with CK4-M2GlyR (n = 3). The outward
current is signi¢cantly larger at 22.5 mM external chloride than
at 149 mM external chloride. (B) The current^voltage relations
obtained at 149 mM external chloride (square, solid line) and
22.5 mM external chloride (down triangle, dotted line) show a
+16 mV shift in reversal potential.
Fig. 5. Scrambled CK4-M2GlyR does not form K-helical sec-
ondary structure. CD spectra of 200 WM CK4-M2GlyR and a
scrambled permutation of CK4-M2GlyR were made using a
Jasco 720 spectropolarimeter in 40% TFE at wavelengths from
175 to 245 nm. The plots are an average of eight scans re-
corded at a rate of 20 nm/min.
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MALSGTTTPGVVKKKK) with the same amino
acid composition as CK4-M2GlyR was synthesized
and used to treat isolated MDCK cells. CD analysis
of the scrambled peptide indicated that this sequence
does not form a helical secondary structure in 40%
TFE (Fig. 5) and thus should not be capable of
forming a helical transmembrane ion-conducting
bundle. This was con¢rmed by planar lipid bilayer
analysis of the scrambled peptide (data not shown).
Treatment with the scrambled CK4-M2GlyR se-
quence (Fig. 2D) did not signi¢cantly alter whole-
cell chloride conductance in MDCK cells. The di¡er-
ence currents obtained for scrambled CK4-M2GlyR-
treated cells were minuscule in amplitude, and com-
parable to those of untreated control cells (Fig. 2D
and A, respectively). In Fig. 3, the mean I^V rela-
tionships for di¡erence currents obtained from
MDCK cells that were untreated (n = 7), treated
with 50 WM CK4-M2GlyR (n = 11), and treated
with 100 WM scrambled CK4-M2GlyR (n = 4) are
shown. The mean changes in whole-cell current for
the scrambled CK4-M2GlyR-treated and the un-
treated control cells do not di¡er signi¢cantly from
zero at any test potential (Fig. 3). In contrast, the
amplitudes of whole-cell currents induced in the
CK4-M2GlyR treated MDCK cells di¡er signi¢-
cantly from both the untreated and scrambled pep-
tide control treatments at all potentials except zero
mV (P6 0.01, ANOVA). These results indicate that
CK4-M2GlyR does not increase whole-cell chloride
conductance in MDCK cells by modulation of en-
dogenous chloride channels via a non-speci¢c elec-
trostatic mechanism.
3.3. Does CK4-M2GlyR modulate the activity of
endogenous epithelial chloride channels?
MDCK and T84 cells are used extensively as mod-
el systems for secretory epithelia and these cell lines
are known to express constitutively: CFTR [27^29],
ClC-2 [30,31], VSOAC [31^33], and Ca2-activated
chloride channels [34^36]. While the data shown
above suggest that CK4-M2GlyR induces a novel
chloride current in epithelial cells, they do not rule
out modulation of endogenous chloride channels by
CK4-M2GlyR in a sequence-speci¢c manner. Addi-
tional experiments were designed speci¢cally to test
for e¡ects of CK4-M2GlyR on CFTR, ClC-2,
VSOAC, and the Ca2-dependent Cl3 channel regu-
lated by CaM kinase.
Like the CK4-M2GlyR-induced current, the
cAMP-activated current associated with CFTR is
time- and voltage-independent. Thus, it was critical
to determine if CK4-M2GlyR increased whole-cell
chloride current by activating CFTR. It has been
shown previously that CK4-M2GlyR does not in-
crease intracellular concentrations of cAMP [11].
To rule out CK4-M2GlyR-activation of CFTR by
other means, the currents induced by CK4-M2GlyR
in IB3-1 cells were compared to the currents induced
in MDCK and T84 cells. IB3-1 cells are an immor-
talized cell line created from a primary culture of
bronchial epithelia isolated from a human patient
with CF; the CF phenotype is preserved in this cell
line [21]. Currents induced by CK4-M2GlyR in IB3-1
Fig. 6. CK4-M2GlyR increases whole-cell conductance in IB3-1
and IB3-1 cells transfected with anti-sense hClC-2. Whole-cell
currents were recorded during step changes in voltage from
380 to +40 mV (step 20) from a holding potential of 340 mV
in IB3-1 cells (left panels), and IB3-1 cells stably transfected
with anti-sense cDNA to hClC-2 (right panels). Current traces
recorded prior to treatment, 30 min after treatment with 50 WM
CK4-M2GlyR, and di¡erence currents, obtained by subtracting
the basal currents from the post-treatment currents, are the in
upper, center and bottom current traces, respectively. The I-V
relations for the CK4-M2GlyR-induced currents indicate that
the properties of the currents induced in these two cell lines are
similar not only to each other, but also to those observed in
MDCK and T84 cells (Figs. 2 and 3). The internal solution
contained 145 mM Tris^HCl, 5 mM MgATP, 5 mM HEPES,
pH 7.45 and the external solution contained 145 mM Tris^HCl,
1 mM MgCl2, 1 mM CaCl2, 60 mM sucrose, 5 mM glucose,
5 mM HEPES, pH 7.45.
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cells were similar to those induced in T84 and
MDCK cells with respect to amplitude, time-, and
voltage-independence (Fig. 6, left panels). The ability
of CK4-M2GlyR to consistently increase whole-cell
chloride conductance in a cell line lacking functional
CFTR argues against stimulation of CFTR as the
dominant mechanism of CK4-M2GlyR action. Fur-
thermore, the similar amplitudes of CK4-M2GlyR-
induced currents in IB3-1, MDCK, and T84 cells
suggest that peptide stimulation of CFTR is insignif-
icant.
ClC-2 channels are ubiquitously expressed in secre-
tory epithelia; expression of ClC-2 in T84 and IB3-1
cells is well documented [17,22,30]. ClC-2 channels
conduct hyperpolarization-activated, pH- and vol-
ume-sensitive chloride currents which exhibit inward
recti¢cation and time-dependent activation at volt-
ages more negative than 320 mV [17,22,30,37]. The
activation kinetics and voltage-dependence of the
currents induced by CK4-M2GlyR (Fig. 2) are incon-
sistent with CK4-M2GlyR-stimulation of ClC-2 as a
mechanism of CK4-M2GlyR action. In addition, cur-
rents induced by CK4-M2GlyR in IB3-1 cells perma-
nently transfected with antisense ClC-2 cDNA [22]
(Fig. 6, right panels) were indistinguishable from
those induced in the IB3-1 cells (Fig. 6, left panels),
and quite comparable to those induced in MDCK
and T84 cells (Fig. 2). These data suggest that
CK4-M2GlyR stimulation of ClC-2 is insigni¢cant.
Ca2-sensitive chloride channels are involved in
£uid and electrolyte movement in Cl3 secreting epi-
thelia [17]. The Ca2-dependent Cl3 currents in T84
cells have been well described. The steady-state cur-
rent voltage relation is strongly outwardly rectifying,
and the activation kinetics are both Ca2 and volt-
age-dependent [35]. In T84 cells, Ca2-dependent Cl3
channels can be activated by ionomycin; the induced
currents are blocked not only by DIDS, but also by
the CaM kinase inhibitor KN-62 [36]. A series of
experiments was conducted to determine if activation
of calcium-dependent Cl3 channels contributes to
the CK4-M2GlyR-induced current in T84 cells. First,
the DIDS sensitivity of the CK4-M2GlyR-induced
current was determined, and compared to the
DIDS sensitivity of ionomycin-induced current. As
expected, a substantial fraction of the ionomycin-in-
duced current was blocked by DIDS (Fig. 7). In
contrast, the DIDS-sensitivity of the CK4-M2GlyR-
induced current was negligible (Fig. 8). Moreover,
CK4-M2GlyR-treatment further increased whole-
cell current in T84 cells previously exposed to iono-
mycin and DIDS. Likewise, ionomycin treatment
after initial exposure to CK4-M2GlyR resulted in
an additional increase in whole-cell chloride conduc-
tance (data not shown). Previously, it was demon-
strated by Arreola et al. [36], that pretreatment
with the CaM kinase inhibitor, KN-62, for 30 min,
markedly inhibits the ionomycin-induced current in
T84 cells. However, pretreatment with KN-62 did
not diminish the CK4-M2GlyR-induced current in
T84 cells (Fig. 9). These pharmacological data
strongly suggest that the CK4-M2GlyR-induced cur-
rent is distinct from the calcium-dependent Cl3
channel in T84 cells.
The electrophysiological properties of the CK4-
M2GlyR-induced current are also di¡erent from
those of the calcium-dependent Cl3 current in T84
cells. The current^voltage relationships of the CK4-
M2GlyR-induced current and ionomycin-induced
currents were compared. As previously described
Fig. 7. DIDS-sensitivity of endogenous chloride currents in T84
cells. Traces recorded before (A) and after application of 10 WM
ionomycin (B), followed by treatment with 200 WM DIDS (C).
The ionomycin-induced (E) and DIDS-sensitive (F) currents
were obtained by subtracting the previously measured current
from the current measured in the presence of the compound of
interest. (D) Current^voltage relations of the ionomycin-induced
(¢lled squares, solid line) and DIDS-sensitive currents (open
squares, dashed line). Whole-cell currents were recorded during
step changes in voltage from 380 to +80 mV (step 20) from a
holding potential of 340 mV. The internal solution contained
145 mM Tris^HCl, 5 mM MgATP, 5 mM HEPES, pH 7.45
and the external solution contained 145 mM Tris^HCl, 1 mM
MgCl2, 1 mM CaCl2, 60 mM sucrose, 5 mM glucose, 5 mM
HEPES, pH 7.45.
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[16,36], the ionomycin-induced current exhibited out-
ward-recti¢cation (Fig. 7). In contrast, the CK4-
M2GlyR-induced current had a linear current^volt-
age relationship (Fig. 8). Furthermore, the ionomy-
cin-induced current clearly showed time- and volt-
age-dependent activation at positive test potentials,
whereas the CK4-M2GlyR-induced current did not
(Figs. 7 and 8, respectively). These data along with
the pharmacological evidence strongly support the
contention that CK4-M2GlyR does not activate the
calcium-dependent Cl3 current.
VSOACs are expressed in MDCK and T84 cells
[31^33]. These volume-sensitive channels are out-
wardly rectifying, and at positive potentials the swell-
ing-activated whole-cell current inactivates [17]. The
activation kinetics and voltage-independence of the
currents induced by CK4-M2GlyR (Figs. 2^5) are
inconsistent with CK4-M2GlyR-stimulation of
VSOAC as a mechanism of CK4-M2GlyR action.
Furthermore, tamoxifen, an agent that completely
Fig. 10. Tamoxifen-sensitivity of CK4-M2GlyR induced cur-
rents in T84 cells. Whole-cell currents of T84 cells were meas-
ured before and after treatment with 100 WM tamoxifen, an in-
hibitor of VSOAC, in an untreated cell (top panel) and a cell
treated with 200 WM CK4-M2GlyR (bottom panel). Tamoxifen
had little or no e¡ect on the endogenous basal current and did
not prevent induction of the novel conductance induced 20 min
after exposure to CK4-M2GlyR. Whole-cell currents were re-
corded during step changes in voltage from 380 to +80 mV
(step 20) from a holding potential of 340 mV. The internal so-
lution contained 145 mM Tris^HCl, 5 mM MgATP, 5 mM
HEPES, pH 7.45 and the external solution contained 145 mM
Tris^HCl, 1 mM MgCl2, 1 mM CaCl2, 60 mM sucrose, 5 mM
glucose, 5 mM HEPES, pH 7.45.
Fig. 9. Calmodulin kinase sensitivity of CK4-M2GlyR-induced
currents in T84 cells. T84 cells were incubated with 10 WM
KN-62, a calmodulin kinase inhibitor, for 30 min in the dark.
Subsequently, the ability of CK4-M2GlyR to increase chloride
conductance in these cells was assessed. Treatment with 200
WM CK4-M2GlyR resulted in an increase in current amplitude
similar to that observed in cells not treated with KN-62. Subse-
quent treatment with ionomycin did not result in a further in-
crease in whole-cell current. The CK4-M2GlyR and ionomycin-
induced currents were obtained by subtracting the currents
measured prior to treatment with the speci¢ed compound from
those measured after treatment. Whole-cell currents were re-
corded during step changes in voltage from 380 to +60 mV
(step 20) from a holding potential of 340 mV. The internal so-
lution contained 145 mM Tris^HCl, 5 mM MgATP, 5 mM
HEPES, pH 7.45 and the external solution contained 145 mM
Tris^HCl, 1 mM MgCl2, 1 mM CaCl2, 60 mM sucrose, 5 mM
glucose, 5 mM HEPES, pH 7.45.
Fig. 8. DIDS-sensitivity of CK4-M2GlyR-induced chloride cur-
rent in T84 cells. Traces recorded before (A) and 20 min after
treatment with 200 WM CK4-M2GlyR (B) followed by treat-
ment with 200 WM DIDS (C). The CK4-M2GlyR-induced cur-
rent (E) was obtained by subtracting the current measured prior
to peptide treatment from the current recorded 20 min after
peptide treatment. The DIDS-sensitive current (F) was obtained
by subtracting the current measured in the presence of DIDS
from the current measured 20 min after peptide treatment. (D)
Current^voltage relations of the CK4-M2GlyR-induced (¢lled
circles, solid line) and DIDS-sensitive currents (open circles,
dashed line). Whole-cell currents were recorded during step
changes in voltage from 380 to +80 mV (step 20) from a hold-
ing potential of 340 mV. The internal solution contained 145
mM Tris^HCl, 5 mM MgATP, 5 mM HEPES, pH 7.45 and
the external solution contained 145 mM Tris^HCl, 1 mM
MgCl2, 1 mM CaCl2, 60 mM sucrose, 5 mM glucose, 5 mM
HEPES, pH 7.45.
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blocks the swelling-activated, outwardly rectifying
current in T84 cells at a concentration of 10 WM
[31], did not prevent CK4-M2GlyR from inducing a
novel Cl3 current in T84 cells (Fig. 10). Taken to-
gether, these data strongly suggest that CK4-
M2GlyR stimulation of VSOAC in isolated epithelial
cells is insigni¢cant.
3.4. Can CK4-M2GlyR form channels from an
aqueous solution in the absence of endogenous
channels?
The M2GlyR sequence, derived from the K-sub-
unit of the brain glycine receptor, was originally
shown to form anion channels when mixed directly
with lipid prior to formation of the bilayers [13].
Based on these ¢ndings, the previously reported ef-
fects of CK4-M2GlyR on epithelial monolayers [11]
and its ability to induce a novel chloride conductance
in isolated epithelial cells (described above) [10], the
lysine-modi¢ed sequence was expected to form chan-
nels in planar lipid bilayers. In contrast to the parent
compound, M2GlyR, the lysine-modi¢ed sequence,
CK4-M2GlyR, was expected to partition into the
bilayer and form channels from an aqueous solution.
In fact, channel activity was observed when CK4-
M2GlyR was introduced to the bilayer chamber at
concentrations as low as 100 nM (Fig. 11). Impor-
tantly, channel activity in lipid bilayers was not ob-
served with the scrambled permutation of the CK4-
M2GlyR sequence under a variety of ionic condi-
tions and with a variety of lipid compositions
(n = 6, data not shown). CK4-M2GlyR forms chan-
nels that, like those formed by M2GlyR [13,14] and
many channel-forming peptides, are ‘noisy’ (Fig. 11).
In addition, the CK4-M2GlyR current in planar lipid
bilayers is time- and voltage-independent (Fig. 11),
consistent with the properties of the CK4-M2GlyR-
induced current in isolated epithelial cells (Figs. 2
and 3). The ability of CK4-M2GlyR to form chan-
nels in a synthetic lipid membrane supports the con-
tention that this peptide is capable of spontaneous
insertion into cell membranes where it assembles into
channel-forming helical bundle structures thereby in-
creasing whole-cell chloride conductance.
4. Discussion
Recent ¢ndings suggest not only that abnormal
chloride transport across epithelial cells, which re-
sults from mutations in the CFTR protein, is impli-
cated in the pathophysiology of CF, but also that the
severity of CF disease is dictated, at least in part, by
the level of residual chloride transport (non-CFTR-
mediated) in a¡ected tissues. For example, residual
Cl3 secretion in CF patients was found to correlate
with preserved pancreatic function and delayed pres-
entation of the disease [5]. In addition, studies of the
CFTR knockout mouse have revealed that the chlo-
ride transporters other than CFTR have a signi¢cant
e¡ect on the phenotype of these mice [6^8]. Restora-
tion of chloride transport to tissues a¡ected by the
CF defect, particularly in the lung, may be a viable
treatment for CF disease. This is the rationale for
developing synthetic chloride-conducting channel-
forming peptides as potential therapeutic agents.
Previously, it was demonstrated that synthetic pep-
tides corresponding to the transmembrane M2 seg-
ment of the K-subunit of the brain glycine receptor
Fig. 11. CK4-M2GlyR channel activity in planar lipid bilayers.
Bilayer traces recorded for 10 s intervals during 20 mV steps
from 380 mV to +80 mV in symmetric 0.1 M KCl. CK4-
M2GlyR was introduced to the trans (grounded) side of the bi-
layer chamber from an aqueous stock solution to obtain a ¢nal
peptide concentration of 100 nM. The voltage protocol is
shown in the upper panel. Bilayer recordings made in the pres-
ence and absence of CK4-M2GlyR are shown in the lower and
center panels, respectively. The solid line in these traces repre-
sents the zero current level. The I-V relation derived from the
means and standard deviations of the bilayer currents recorded
in the absence (circles, dashed line) and presence of CK4-
M2GlyR (square, solid line-obtained by linear regression) is
shown on the right.
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form anion-selective channels in phospholipid bi-
layers [12]. In addition, it was found that modifying
the hydrophobic membrane-derived M2GlyR se-
quence by addition of four lysines to the C-terminus
(CK4-M2GlyR) results in a peptide with enhanced
aqueous solubility that is capable of inducing trans-
epithelial chloride and £uid secretion when added to
the apical surface of MDCK monolayers [10]. Based
on these ¢ndings [11], this peptide may be a candi-
date for introducing an alternative chloride permea-
tion pathway in CF-a¡ected tissues.
The goals of the present study were to determine
whether CK4-M2GlyR could exert e¡ects on whole-
cell chloride conductance in isolated epithelial cells,
and if the observed e¡ects were the result of forma-
tion of a novel chloride conductance pathway, mod-
ulation of endogenous chloride channel activity, or a
combination of these e¡ects. The major ¢ndings of
this communication are that extracellular application
of CK4-M2GlyR to isolated MDCK, T84, and IB3-1
cells resulted in increased permeability of the cells to
chloride. The experimental evidence suggests a direct
mechanism of action.
For example, the lack of increase in whole-cell
current in MDCK cells treated with scrambled
CK4-M2GlyR suggests that the poly-lysine tail of
CK4-M2GlyR does not activate endogenous CFTR
channel activity in a manner similar to that observed
with protamine in airway epithelial cells [14]. One
potential caveat to the scrambled CK4-M2GlyR as
a control for electrostatic e¡ects of the peptide is that
its partitioning and membrane localization are di¡er-
ent than for the K-helical native sequence. It is fea-
sible that a transmembrane sequence is required for
the electrostatic e¡ect of the poly-lysine tail to acti-
vate CFTR. However, an idealized amphipath based
on the CK4-M2GlyR peptide retains the secondary
structure of the native M2GlyR sequence but does
not form channels in planar lipid bilayers and has no
e¡ect on ISC in MDCK monolayers [38]. Taken to-
gether, these ¢ndings suggest that a poly-lysine modi-
¢ed K-helical peptide is not su⁄cient to activate en-
dogenous CFTR by an electrostatic mechanism.
In addition, the ability of CK4-M2GlyR to induce
a time- and voltage-independent current in the IB3-1
cell line, which lacks functional CFTR, suggests that
CK4-M2GlyR does not increase chloride current by
activating CFTR. The time- and voltage-independ-
ence of the CK4-M2GlyR-induced current, as well
as the pharmacological pro¢le of the induced cur-
rent, strongly suggest that CK4-M2GlyR does not
activate other endogenous chloride currents in the
isolated epithelial cells, speci¢cally: the hyperpolari-
zation activated current associated with ClC-2, the
swelling-activated current associated with VSOAC,
the Ca2-dependent Cl3 current activated by CaM
Kinase II. Together, these results support the prem-
ise that the M2GlyR peptides increase ISC in epithe-
lial monolayers by forming a novel permeation path-
way for chloride rather than by activation of
endogenous chloride conductances. Recordings of
CK4-M2GlyR-induced single channel events in iso-
lated epithelial cells are needed to determine fully the
electrophysiological properties of the channels
formed by CK4-M2GlyR in biological membranes.
It is particularly noteworthy that treatment of the
immortalized airway cell line that carries the CFTR
mutation (IB3-1) with CK4-M2GlyR resulted in en-
hanced whole-cell chloride conductance. In terms of
the eventual goal to use an M2GlyR peptide as a
therapeutic treatment for CF, it is important to con-
sider how the activity of the peptide channel would
be regulated. We assume that the CK4-M2GlyR cur-
rent would respond to changes in chloride driving
force and that this would be the level at which con-
trol would occur. In whole-cell studies, the CK4-
M2GlyR-induced chloride current increases in the
inward direction when the external chloride concen-
tration is lowered. This is the expected result for a
chloride-selective current when the driving force for
e¥ux of chloride has been increased. Furthermore,
we have shown that CK4-M2GlyR acts synergistical-
ly with EBIO to enhance chloride secretion across
T84 monolayers [39]. EBIO activates a basolateral
potassium channel, which in turn increases the activ-
ity of the basolateral NaK2Cl3 cotransporter re-
sulting in an increase in the driving force for chloride
secretion [39]. In the presence of CK4-M2GlyR at the
apical surface and EBIO at the basolateral surface of
T84 monolayers, chloride secretion was dramatically
increased above that of untreated monolayers or
monolayers treated with either agent alone. Taken
together, these ¢ndings suggest that CK4-M2GlyR-
mediated chloride transport is regulated by changes
in chloride driving force. Further studies will be re-
quired to determine whether regulation by changes in
BBAMEM 77836 12-5-00
K.E. Mitchell et al. / Biochimica et Biophysica Acta 1466 (2000) 47^60 57
Cl3 driving force alone is su⁄cient for the chloride
secretion produced by CK4-M2GlyR to act as an
adequate replacement for CFTR-mediated chloride
transport.
As expected, CK4-M2GlyR retains the ability of
its parent sequence, M2GlyR, to form channels in
planar lipid bilayers. In contrast to the M2GlyR pep-
tide, which must be delivered to planar bilayers in
lipid vesicles or mixed with lipid prior to bilayer
formation [12,13], CK4-M2GlyR forms channels in
planar lipid bilayers or isolated cells when applied
as an aqueous solution. These properties, aqueous
solubility and lipid partitioning, of the CK4-
M2GlyR peptide may be useful in developing this
compound as a therapeutic agent; they suggest that
delivery and insertion of the peptide into a¡ected
tissues may be feasible with an aerosolized or inject-
able solution.
Signi¢cantly, treatment of cells with CK4-M2GlyR
during whole-cell patch clamp or Ussing chamber
experiments does not result in either seal breakdown
or loss of monolayer resistance, respectively [11] as
would be expected if the peptide had acute adverse
e¡ects on membrane integrity or cell viability. These
¢ndings along with studies in which CK4-M2GlyR
was found to have an insigni¢cant e¡ect on release
of lactate dehydrogenase (a measure of cytotoxicity)
or cell growth rates at concentrations up to 1 mM
during 24 h treatments of MDCK, T84 or IB3 mono-
layers [40] suggest that the utility of the CK4-
M2GlyR peptide as a therapeutic agent in CF will
not be limited by acute cytotoxicity.
In summary, this investigation shows for the ¢rst
time that a synthetic channel forming peptide based
on the sequence of an endogenous ion channel can
spontaneously insert into the plasma membrane of
an isolated mammalian cell, and increase measured
whole-cell currents by forming a novel permeation
pathway, without either perturbing existing constitu-
tive conductance pathways or compromising cell vi-
ability. The feasibility of developing CK4-M2GlyR
and/or other synthetic channel forming peptides as
therapeutic agents for treatment of diseases associ-
ated with ion channel defects is as yet uncertain.
Further investigation of this potential is warranted,
especially for diseases like CF where existing treat-
ments are not completely safe nor e¡ective.
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